Bristol-Myers Squibb Company
Utility Patents
Last updated:
List of all Bristol-Myers Squibb Company patents 334 in total
| Status | Patent |
|---|---|
Grant | Utility: Targeted therapeutics based on engineered proteins that bind EGFR Filling date: 6 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Filling date: 6 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins Filling date: 6 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: GSK-3 inhibitors Filling date: 6 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Fast-off rate serum albumin binding fibronectin type III domains Filling date: 6 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: GSK-3 inhibitors Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Diamide macrocycles having factor XIa inhibiting activity Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Indazole derivatives as .alpha.v integrin antagonists Filling date: 6 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Compounds useful as immunomodulators Filling date: 6 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Use of caprylic acid precipitation for protein purification Filling date: 6 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: 4-Azaindole compounds Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Bridged bicyclic compounds as farnesoid X receptor modulators Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Bicyclic heteroaryl substituted compounds Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Biaryl kinase inhibitors Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitors Filling date: 6 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Pyrrolidine GPR40 modulators Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 |
Grant | Utility: Pyrrole amides as alpha V integrin inhibitors Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 |
Grant | Utility: Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Tricyclic sulfones as ROR.gamma. modulators Filling date: 6 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Substituted bicyclic compounds Filling date: 6 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Spirolactams as inhibitors of ROCK Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Use of alkaline washes during chromatography to remove impurities Filling date: 6 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: IDO inhibitors Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Anti-GITR antibodies for cancer diagnostics Filling date: 6 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Antibodies against OX40 and uses thereof Filling date: 6 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: Tricyclic compounds as anticancer agents Filling date: 6 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: Carbazole derivatives Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Phenylpyrrolidinone formyl peptide 2 receptor agonists Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Quinazolines as potassium ion channel inhibitors Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Antibodies conjugatable by transglutaminase and conjugates made therefrom Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Substituted naphthyridinone compounds useful as T cell activators Filling date: 6 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: 3-sulfonyl-5-aminopyridine-2,4-diol APJ agonists Filling date: 6 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Heteroarylhydroxypyrimidinones as agonists of the APJ receptor Filling date: 6 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Pyridyl substituted indole compounds Filling date: 6 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Tricyclic rho kinase inhibitors Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Antibodies comprising modified heavy constant regions Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Tricyclic sulfone compound as a ROR gamma modulator Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Substituted tricyclic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Showing 200 to 250 of 334 patents.